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ABSTRACT
A rapid method for the synthesis of oligodeoxy-
nucleotides (ODNs) terminated by 5'-amino-5'-deoxy-
thymidine is described. A 3'ophosphorylated ODN (the
donor) is incubated in aqueous solution with 5'-amino-
5'-deoxythymidine in the presence of N-(3-dimethyl-
aminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC),
extending the donor by one residue via a
phosphoramidate bond. Template- directed ligation of
the extended donor and an acceptor ODN, followed by
acid hydrolysis, yields the acceptor ODN extended by a
single 5'-amino-5'-deoxythymidine residue at its
5' terminus.
Oligodeoxynucleotides (ODNs) containing a terminal amino
functionality are of considerable interest for the construction of
bioconjugates with novel properties. The presence of the amine
allows selective attachment of various ligands, including reporter
groups (1,2) and peptide epitopes (3,4). A terminal amine is
readily attached to an ODN via a non-nucleotide linker. In some
instances, however, it is preferable that the ODN itself contains
a terminal 5'-amino-5'-deoxynucleoside. The requisite 5'-amino-
5'-deoxynucleoside phosphoramidites are not commercially
available. Preparation of these compounds (1,2,5) involves a
difficult multi-step synthesis that is not easily carried out in most
molecular biology laboratories. This prompted us to develop a
simple procedure tor the preparation of 5'-amino-terminated
ODNs that can be conducted in any laboratory without the use of
sophisticated chemical equipment (Fig. 1).
A commercially available 3'-phosphorylated 'donor' ODN
(DNA-1) was converted to a phosphoramidate-linked ODN one
residue greater in length (Fig. 2, lanes 1 and 2). In a typical
reaction, 0.01 M donor ODN was treated with 0.1 M
5'-amino-5'-deoxythymidine (Sigma) and 0.15 M EDC in 0.1 M
2-methylimidazole (2-MeIm) buffer (pH 7.0) (6). The reaction
was complete after 2-4 h at 50°C, furnishing the modified donor
ODN in 60-90% yield. 5'-amino-5'-deoxyadenosine is also
available for use in this reaction.
The donor ODN was extended on the 3' side of the
phosphoramidate linkage either by template-directed ligation to
an 'acceptor' ODN (DNA-2) (Fig. 2, lanes 3-5) or by extension
using a DNA-dependent DNA polymerase (7). When a 32p label
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Figure l. Scheme for the synthesis of 5'-amino-terminated ODNs. First,
condensation of a 3' phosphorylated 'donor" ODN (DNA-I) and 5"-amino-
5'-deoxythymidine in the presence of EDC and 2-Melm yields a phosphor-
amidate-linked ODN intermediate. Next, enzymatic ligation of this intermediate
and a 5'-phosphorylated 'acceptor' ODN (DNA-2) in the presence of a
complementary template (TEM) places the 5'-amino-5'-deoxythymidine
residue immediately upstream of DNA-2. Finally, cleavage of the phosphor-
amidate bond under acidic conditions furnishes the 5'-amino-5'-deoxythymi-
dine-terminated product.
was desired, 0.1 laM [5'-32p]DNA-2, 2.5 laM extended DNA-1
and 2.5 laM of the corresponding DNA template (TEM) were
incubated in the presence of ! U/gl T4 DNA ligase, 20 mM
Tris-HC1 (pH 7.5), i0 mM MgCI2, 10 mM DTT and 1 mM ATP
at 23 °C for 2 b. The ligation of very short ODNs (e.g. a 5mer) was
performed at 16°C for 24 h. When 32p labeling was not required,
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Figure 2. Analysis by denaturing polyacrylamide gel electrophoresis of
reaction intermediates and products depicted in Figure 1. Lane 1,
5'-32p-labeled DNA-1 having the sequence 5'-GGACTGATGCTATGp-3'.
Lane 2, condensation of DNA- 1 and 5'-amino-5'-deoxythymidine, followed by
labeling of the reaclion mixture with T4 polynucleotide kinase and [],-32p]ATP
to yield [5'-32p]DNA-IpN T. Lane 3, 5'-32p-labeled DNA-2 having the
sequence 5'-pCACGAGCGAGTCT-3'. "Lane 4, enzymatic ligation of unlabeled
DNA-IpNT and 5'-32p-labeled DNA-2 in the presence of a complementary
template having the sequence 5'-AGACTCGCTCGTGACATAGCAT-
CAGTCC-3'. Lane 5, ligation reaction as in lane 4, but in the absence of the
template. Lane 6, gel-purified [igation product DNA-IpNT[32p]DNA-2.
Lane 7, acid cleavage oftbe ligation product to yield H2NT[ 32p]DNA_2. "Lane 8,
gel-purified H2NT[32p]DNA-2. Lane 9, derivitization of the 5'-amine of
IIzNT[32p]DNA-2 using su[fosuccinimidyl-6-(biotinarnido) hexanoate.
the concentration of each ODN was increased to 10 laM and the
amount of ligase was increased to 4 U/p.I. The presence of the
phosphoramidate linkage upstream of the ligation junction did
not inhibit the activity of T4 DNA ligase.
The phosphoramidate linkage is labile under acidic conditions
(8). Incubation of the ligation product in 50% acetic acid at 23°C
for >3 h resulted in the release of the 5'-amino-5"-deoxythymi-
dine-derivitized acceptor ODN (Fig. 2, lanes 6 and 7). The ODN
product may be purified by HPLC or polyacrylamide gel
electrophoresis. Purification is facilitated by designing the donor
and template ODNs such that they differ in size compared to the
desired product. The identity of the phosphoramidate-linked
ODN intermediate and the 5'-amino-terminated ODN product
were confirmed by matrix-assisted laser desorption ionization
(MALDI) mass spectrometry (data not shown). The 5'-amino-
terminated ODN product was biotinylated upon incubation with
25 mg/ml sulfosuccinimidyl-6-(biotinamido) hexanoate (Pierce
Chemical) in 70 mM NaHCO3 (pH 8.5) at 23°C for 1 h,
confirming the availability of the primary amine (Fig. 2, lanes 8
and 9).
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